A recent meta-analysis on BRCA-associated prostate cancer risk and mortality also reported an increased mortality in BRCA2 carriers and concluded that BRCA2 but not BRCA1 mutations were associated with higher prostate cancer mortality [15]. Here, BRCA1 is linked to prostate carcinoma.